Arbutus Biopharma Corporation

IPO

Home - Arbutus Biopharma

Arbutus Biopharma Corporation is a biotech company in Burnaby, Canada, founded in 2015. It has raised $116.0M across 1 round, most recently a $116.0M Corporate Round in October 2017.

Headquarters
Burnaby
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$116.0M
Last Round
$116.0M Corporate RoundOct 2017
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. to use credits for reveals, or explore the API.

About

Arbutus Biopharma (Nasdaq: ABUS) is a clinical-stage biopharmaceutical company focused on developing a functional cure for chronic hepatitis B virus (HBV) infection. Its pipeline includes RNAi therapeutics, immune modulators, and antivirals designed to be used in combination to suppress the virus and restore immune control in patients.

Funding History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundOct 2017
$116.0M

Investors

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×2
  • DevOps ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Arbutus Biopharma Corporation on Indexed.vc
<a href="https://indexed.vc/companies/arbutus-biopharma-corporation"><img src="https://indexed.vc/api/badge/company/arbutus-biopharma-corporation" alt="Arbutus Biopharma Corporation on Indexed.vc" width="260" height="76" /></a>